1. Home
  2. EVO vs AAT Comparison

EVO vs AAT Comparison

Compare EVO & AAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • AAT
  • Stock Information
  • Founded
  • EVO 1993
  • AAT 1967
  • Country
  • EVO Germany
  • AAT United States
  • Employees
  • EVO N/A
  • AAT N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • AAT Real Estate Investment Trusts
  • Sector
  • EVO Health Care
  • AAT Real Estate
  • Exchange
  • EVO Nasdaq
  • AAT Nasdaq
  • Market Cap
  • EVO 1.6B
  • AAT 1.7B
  • IPO Year
  • EVO 2021
  • AAT 2011
  • Fundamental
  • Price
  • EVO $4.50
  • AAT $27.49
  • Analyst Decision
  • EVO Buy
  • AAT Hold
  • Analyst Count
  • EVO 2
  • AAT 2
  • Target Price
  • EVO $5.90
  • AAT $26.00
  • AVG Volume (30 Days)
  • EVO 152.3K
  • AAT 249.8K
  • Earning Date
  • EVO 11-06-2024
  • AAT 02-04-2025
  • Dividend Yield
  • EVO N/A
  • AAT 4.87%
  • EPS Growth
  • EVO N/A
  • AAT 17.42
  • EPS
  • EVO N/A
  • AAT 0.97
  • Revenue
  • EVO $866,665,179.00
  • AAT $452,499,000.00
  • Revenue This Year
  • EVO $4.56
  • AAT N/A
  • Revenue Next Year
  • EVO $13.44
  • AAT N/A
  • P/E Ratio
  • EVO N/A
  • AAT $28.44
  • Revenue Growth
  • EVO N/A
  • AAT 5.13
  • 52 Week Low
  • EVO $2.85
  • AAT $20.03
  • 52 Week High
  • EVO $12.00
  • AAT $29.15
  • Technical
  • Relative Strength Index (RSI)
  • EVO 49.65
  • AAT 45.30
  • Support Level
  • EVO $4.39
  • AAT $27.37
  • Resistance Level
  • EVO $4.81
  • AAT $28.02
  • Average True Range (ATR)
  • EVO 0.13
  • AAT 0.46
  • MACD
  • EVO -0.05
  • AAT -0.10
  • Stochastic Oscillator
  • EVO 45.24
  • AAT 9.82

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

Share on Social Networks: